Wnt/b-catenin signaling plays a pivotal role in modulating cellular proliferation, differentiation, tissue organization and embryonic development. Earlier, we found that the endocytic adaptor disabled-2 (Dab2) could attenuate Wnt/ b-catenin signaling by stabilizing Axin and preventing its translocation to the membrane. Recently, protein phosphatase 1 (PP1) has been shown to interact with, and dephosphorylate Axin, leading to its destabilization. Here, we show that Dab2 functions upstream of PP1 to block the interaction between Axin and PP1, inhibiting Axin dephosphorylation and thereby stabilizing its expression, ultimately leading to inhibition of Wnt/b-catenin. We show that Dab2 acts as a competitive inhibitor of PP1 by binding to the same C-terminal domain of Axin. Both PP1 and Axin bind to the N-terminus of Dab2 and a Dab2 truncation mutant consisting of the N-terminal phosphotyrosine binding domain blocks PP1-Axin interactions and inhibits Wnt signaling. We confirm the inhibitory effect of Dab2 on Wnt/b-catenin signaling in zebrafish embryos, showing that its ectopic expression phenocopies Axin overexpression resulting in altered dorsoventral patterning. We conclude that Dab2 stabilizes Axin and attenuates Wnt/b-catenin signaling by preventing PP1 from binding Axin.
Wnt signaling is critical for a wide range of developmental and physiological processes, and it is implicated in human disease, including cancer (Bienz and Clevers, 2000) . Stabilization and translocation of intracellular b-catenin into the nucleus are essential in 'canonical' Wnt signaling. b-catenin stabilization is regulated by a multimeric b-catenin destruction complex that contains, among others, dishevelled proteins (Dvl), Axin, adenomatous polyposis coli, casein kinase 1 and glycogen synthase kinase 3 (GSK3). In this complex, b-catenin is sequentially phosphorylated and earmarked for degradation by the proteasome. Wnt promotes destabilization of the b-catenin destruction complex and inhibition of b-catenin phosphorylation and degradation (van Noort et al., 2002) . How b-catenin is stabilized in response to Wnt is not clear. Recent studies show that the intracellular domain of the LRP5/6 co-receptors can bind and recruit Axin to the plasma membrane (He et al., 2004) . Wnt stimulation induces the sequential phosphorylation of LRP5/6 co-receptor by a 'dual kinase' mechanism involving GSK3 and casein kinase 1 at multiple PPPSP sites (Zeng et al., 2005) . This phosphorylation of LRP5/6 promotes the recruitment and engagement of LRP5/6 with Axin (Zeng et al., 2005) . Dvl aids in the Wnt-induced recruitment of Axin to the membrane and to its interaction with the phosphorylated LRP5/6 co-receptor, which ultimately leads to its dephosphorylation and degradation (Cliffe et al., 2003) . Recently, protein phosphatase 1 (PP1) has been shown to interact with and dephosphorylate Axin and that its dephosphorylation is associated with its destabilization (Luo et al., 2007) . As the levels of Axin are decreased, the destruction complex is destabilized, and b-catenin levels accumulate. As Axin also serves as a cytoplasmic anchor for b-catenin, when Axin is absent, accumulated b-catenin is free to translocate into the nucleus and activate the transcription of Wntresponsive genes (Jones and Bejsovec, 2003) .
The (disabled-2) Dab2 is a widely expressed endocytic adaptor protein shown to be involved in several receptor-mediated signaling pathways (Prunier et al., 2004) . Dab2 contains a conserved N-terminal phosphotyrosine binding (PTB) domain (Yun et al., 2003) that binds to members of the lipoprotein receptor (LDLR) family and with phosphoinositides (Morris and Cooper, 2001) . Dab2 binds clathrin, the clathrin adaptor protein, AP2, and myosin VI, facilitating clathrin-coated pit assembly and receptor-mediated endocytosis (Morris and Cooper, 2001; Morris et al., 2002) . The endocytic and vesicular trafficking functions of Dab2 are postulated to mediate its effects on cellular signaling (Morris et al., 2002) . Earlier, we reported that Dab2 functions as a negative regulator of canonical Wnt signaling by stabilizing the b-catenin destruction complex (Hocevar et al., 2003) . We showed that Dab2 associates with Axin and prevents Axin association, and subsequent degradation, with the LRP5 co-receptor, resulting in a stabilization and an increase in the half-life of Axin (Jiang et al., 2008) . Here, we report that Dab2 stabilizes Axin by preventing its interaction with and subsequent dephosphorylation by PP1. The PTB domain of Dab2 is shown to bind to both Axin and PP1 in a mutually exclusive manner. In addition, we show that ectopic expression of Dab2 phenocopies Axin overexpression in altering dorsoventral patterning in zebrafish embryos.
Recently, PP1 has been shown to serve as a positive regulator of Wnt/b-catenin signaling through its ability to interact with, dephosphorylate, and destabilize Axin (Luo et al., 2007) . As we have shown that Dab2 stabilizes Axin expression levels, thereby inducing a more active b-catenin destruction complex (Jiang et al., 2008) , we postulated that Dab2's stabilization of Axin may be mediated through PP1. To test this, we investigated the effects of ectopically expressed Dab2 on PP1-modulated Wnt/b-catenin signaling in mouse F9 cells. Titration of increasing concentrations of PP1 ( Figure 1a ) resulted in a dose-dependent increase in Wnt-induced TOPFLASH (a) and cyclin D1 (b) luciferase activity, confirming the reported positive regulatory role of PP1 on Wnt/b-catenin signaling (Luo et al., 2007) . We next titrated PP1 function with increasing concentrations of Dab2, and this led to the downregulation of Wnt3a-induced TOPFLASH and cyclin D1 luciferase activities (Figures 1a and b) . Thus, overexpressed Dab2 can block the potentiating effects of PP1 on Wnt/b-catenin signaling. To determine whether endogenous Dab2 could also attenuate PP1-induced Wnt/b-catenin signaling, we treated F9 cells with retinoic acid (RA) for 72 h, conditions that induce visceral endoderm differentiation concomitant with significant induction of Dab2 (Smith et al., 2001 ). RA-induced, endogenous Dab2 is capable of attenuating the effects of PP1 on Wnt3a-induced TOPFLASH and cyclin D1 luciferase activities (Figure 1c ). Inset ( Figure 1c) shows that RA induces Dab2, which leads to Axin stabilization. To substantiate Dab2's inhibitory effects on TOPFLASH and cyclin D1 luciferase, similar experiments were performed in F9 cells with stable small interfering RNA (siRNA)-mediated silencing of Dab2 (F9-siDab2 cells; Prunier and Howe, 2005) . The data presented in Supplementary Figure S1a show that RA does not induce Dab2 in these cells and that Axin is not stabilized, nor is TOPFLASH or cyclin D1 luciferase activity attenuated. These data show that PP1 is a positive regulator of Wnt/b-catenin signaling, and that Dab2 can block not only Wnt3a-induced but also PP1's upregulation of Wnt/b-catenin signaling.
We next examined the effects of PP1 and Dab2 expression on Axin levels. Expression of increasing concentrations of PP1 resulted in a dose-dependent reduction in the expression of exogenous and endogenous Axin (Figure 1d and Supplementary Figure S1b Given that PP1 interacts with and mediates dephosphorylation of Axin (Luo et al., 2007) , we tested whether Dab2 could prevent PP1-Axin interactions and thus lead to Axin stabilization. F9 cells were cotransfected with Myc-tagged Axin and increasing concentrations of Flag-tagged Dab2, and a-Myc coprecipitating proteins were analysed by immunoblotting. In the absence of Dab2, endogenous PP1 is coprecipitated in an Axin immunoprecipitate ( (Figure 2b ). RA-induced, endogenous Dab2 similarly prevents endogenous Axin-PP1 interactions and also co-precipitates in an Axin IP, indicating interaction between Dab2 and Axin ( Figure 2c ). Endogenous Dab2 also inhibits the amount of endogenous PP1 co-precipitating in an Axin IP (Figure 1c) . These results show that Dab2 inhibits PP1-Axin interactions, preventing PP1-mediated dephosphorylation of Axin, stabilizing Axin and its association with Gsk3b, resulting in increased b-catenin phosphorylation and degradation.
To gain insight into the mechanism through which Dab2 inhibits Axin-PP1 interactions, we assessed the contribution of individual Dab2 and Axin domains. We performed reciprocal co-immunoprecipitation (co-IP) (Figures 3b and c) . In addition, we
found that the C-terminal of Axin is responsible for interacting with the Wnt co-receptor, LRP5 (Figure 3d ). These data show that the C-terminal of Axin is responsible for binding LRP5, PP1 and Dab2 and suggests that these may compete with one another and/ or physically displace each other in binding to Axin. To . After a 24 h tranfection, WCLs were subjected to immunoprecipitation with control IgG or a-Myc antibody. The immunocomplexes were separated by SDS-PAGE, and subjected to immunoblot analysis using a-PP1, a-Flag, a-Gsk3b and a-Myc antibodies. To blot for phosphorylated Axin, the a-Myc (Axin) blot was stripped and re-probed with a-p-Ser antibody. (b) Increasing concentrations of Flag-tagged Dab2 (2, 4 and 6 mg) and Myc-tagged Axin (5 mg) were co-transfected in F9 cells, and after a 24 h transfection, cells were treated with 30 nM MG-132 for 4 h. WCLs were collected and subjected to immunoblotting using a-p-b-catenin, a-b-catenin, a-Myc, a-Dab2 and a-Hsp90 antibodies. (c) RA-induced endogenous Dab2 blocks Axin-PP1 interactions. F9 cells and F9-siDab2 cells were treated with RA (100 nM) for 72 h, and 6 mg WCLs were prepared and immunoprecipitated with a-Axin antisera. Immunocomplexes were analysed by SDS-PAGE and subjected to immunoblot analysis using a-PP1, a-Dab2 and a-Axin antibodies.
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further delineate the domain of Dab2 required for binding to Axin and PP1, we co-transfected Myc-tagged Axin (Figure 3e ) or Myc-tagged PP1 (Figure 3f ) with either full-length or truncation mutants of Dab2 and performed reciprocal co-IPs. The data show that the Nterminal of Dab2, residues 1-247, encompassing the PTB domain, is required for binding to both Axin and PP1. To determine whether a functional PTB domain is necessary for Dab2-Axin interaction, increasing concentrations of a non-functional PTB domain mutant F166V (Hocevar et al., 2001 ) was co-transfected with Myc-Axin. The results (Figure 3h) 
Earlier studies have shown that Axin plays an important role in the establishment of the dorsoventral axis during zebrafish embryogenesis (Rui et al., 2007) . As our data suggest that Dab2 expression regulates Axin levels, we investigated the effect of ectopic expression of Dab2 on embryonic development in zebrafish embryos. We injected Dab2 mRNA (600 pg) into one-cell stage embryos, and 24-h post-fertilization (hpf) we observed two different populations of abnormal embryos. Shown in Figure 4a are the lateral views of two representatives, live embryos exhibiting either a ventralized or dorsalized phenotype. The dorsalized phenotype exhibits a shortened tail and lack of the ventral tail fin. The ventralized phenotype lacks a head and notochord and has a large blood island compared with the normal phenotype. These two phenotypes have earlier been observed after Axin mRNA microinjection (Rui et al., 2007) . Thus, ectopic expression of Dab2 seems to phenocopy Axin in modulation of dorsoventral patterning. To further characterize Dab2's dorsoventral patterning activities, we injected Dab2, Axin and PP1 mRNAs singly or in various combinations and determined phenotypic effects 24 hpf. (Luciferase mRNA was used as control for equal (800 pg total) mRNA injection.) The results (Figure 4b) show that both injected Axin and Dab2 mRNA induced altered phenotypes. A dose of 200 pg/embryo of injected Dab2, induced an altered phenotype in B25.4% of the embryos (n ¼ 146), with B14.4% being ventralized and B11% being dorsalized (column 1). At a dose of 200 pg/ embryo, injected Axin mRNA induced an altered phenotype in 32.6% of the injected embryos (n ¼ 138), with B17.4% of these exhibiting a dorsalized and B15.2% exhibiting a ventralized phenotype, respectively (column 2). At a dose of 400 pg/embryo, injected Axin mRNA induced an altered phenotype in 68% of the injected embryos (n ¼ 132), with B31.8% of these exhibiting a dorsalized and B37.8% exhibiting a ventralized phenotype, respectively (column 5). A dose of 400 pg/embryo of injected Dab2 induced an altered phenotype in B56.3% of the embryos (n ¼ 112), with B28.6% being ventralized and B27.7% being dorsalized (column 8). No phenotypic alterations were observed with injected PP1 mRNA (200 and 400 pg/ embryo; data not shown). When mRNAs were coinjected, we observed that Dab2 could potentiate in a dose-dependent manner the phenotypic effects of low doses of injected Axin mRNA (columns 2, 3 and 4). Further, although PP1 mRNA was without effect when injected alone, it was capable of attenuating, in a dosedependent manner, the Axin phenotype (columns 5, 6 and 7). When co-injected with Dab2, however, PP1 could not reverse the phenotype induced by Dab2 mRNA injection (columns 8, 9 and 10). We also injected Dab2 mRNA together with the standard control and Axin morphilinos (columns 11-14) and observed that Dab2's phenotypic effects are neutralized by Axin, but not control, morpholinos. These data show that Dab2 requires Axin function to induce effects on dorsoventral patterning. Finally, the relative dorsoventral patterning activities of the various Dab2 truncation mutants (b) Dab2, Axin, PP1 or luciferase (control) mRNAs were injected, into one-cell stage embryos, alone or in various combinations and at the doses indicated. Live embryos were collected 24 hpf and observed under a microscope. The percentage of embryos displaying an altered phenotype was quantitated based on the total number of injected embryos (n) and these were further categorized based on displaying either a dorsalized or ventralized phenotype. Data are presented as mean±s.d. and show significant alterations in dorsalventral phenotypes ( * significant) across injection groups. Pairwise comparison was performed by t-test, multiple comparisons by ANOVA using SigmaStat 3.5 software. The differences among injections 1, 2, 3 and 4 are significant, Po0.01. The differences among 5, 6 and 7 are significant, Po0.01. The differences among 8, 9 and 10 are not significant, P>0.05. The difference between 11 and 12 is significant, Po0.001, so is the difference between 13 and 14. The differences among 15, 16/17 and 18 are significant, Po0.01. (c-e) Expression of injected mRNAs in embryos. (c) Myc-tagged Axin mRNA (200 pg) and increasing concentrations of Flag-tagged Dab2 were co-injected into one-cell embryos. After a 10 h incubation, embryos lysates were processed for immunoprecipitations using a-Flag and a-Myc antibodies. The immunocomplexes were analysed by SDS-PAGE and immunoblot analysis to detect ectopic Dab2 (a-Flag) and Axin (a-Myc) protein expression levels. (d) Myc-tagged Axin mRNA (400 pg) and increasing concentrations of Myc-tagged PP1 were co-injected into one-cell embryos. Embryos were processed and analysed as in (c) to detect ectopically expressed PP1 (a-Myc) and Axin (a-Myc). (e) FL-Flag-tagged or truncated Dab2 deletion constructs were injected into one-cell embryos. Embryos were processed and analysed as in (c and d) to detect ectopically expressed FL-Dab2 and its indicated truncation mutants (a-Flag). Figure 4c -e show the protein levels of the various injected mRNAs prepared from embryo lysates subjected to immunoprecipitation and immunoblotting analyses. As predicted, ectopic expression of Dab2 enhanced ectopic Axin expression levels (Figure 4c ), whereas overexpression of PP1 results in significant downregulation of Axin (Figure 4d ). Comparable expression levels of full-length Dab2 and its truncation mutants are also shown (Figure 4e ). In summary, these data show that Dab2 alters dorsoventral patterning during zebrafish development, resulting in a morphology that is indistinguishable from that mediated by ectopic expression of Axin. Although injection of PP1 mRNA alone did not have any effect, it attenuated the Axin-induced, but not the Dab2-induced, phenotype, suggesting that PP1 function is required downstream of Axin but not of Dab2. The data also show that the functional PTB domain of Dab2, responsible for binding Axin and PP1 (Figure 3 ), is only B50% as effective in mediating the observed effects of full-length Dab2. This suggests that full-length Dab2, similarly to Axin, blocks other Wnt-induced dorsoventral patterning pathways, and that its PTB domain is effective in inhibiting solely the Wnt/b-catenin branch.
In summary, our results suggest a model ( Figure 5 ) whereby in the absence of elevated levels of Dab2 (a), the b-catenin destruction complex is recruited to the Fz/ LRP5/6 receptor complex, which promotes Axin-PP1 interactions, leading to the dephosphorylation and destabilization of Axin, disassembly of the complex, resulting in increased b-catenin and Wnt signaling. In the presence of Dab2 (b), Dab2 prevents recruitment of the b-catenin destruction complex to the receptors, Axin-PP1 interactions do not occur, thereby Axin levels are maintained, and b-catenin is degraded and Wnt signaling is attenuated. How and where in the cell Dab2 blocks Axin-PP1 interactions is not clear. Recently, it has been shown that Wnt induces co-clustering of receptors and Dvl in 'LRP6 signalosomes' promoting LRP6 phosphorylation and recruitment of Axin leading to b-catenin stabilization (Bilic et al., 2007) . It has also been suggested that this clustering occurs in caveolincontaining vesicles and that endocytosis through these lipid rafts ultimately leads to Axin destabilization and bcatenin accumulation (Yamamoto et al., 2008) . Interestingly, clathrin-mediated endocytosis of the 'LRP6 signalosome' was shown not to lead to b-catenin accumulation and induction of Wnt signaling (Yamamoto et al., 2008) . As Dab2 has been shown earlier to bind to the clathrin adaptor AP2, as has Dvl2 (Yu et al., 2007) , and be involved in clathrin-mediated endocytosis (Morris and Cooper, 2001) , it is tempting to speculate that Dab2 may recruit the 'LRP6 signalosome' to this endocytic route to attenuate Wnt-mediated signaling.
